Publications by authors named "C Chouaid"

Claim this Profile
T
Timing of Immunotherapy in Practice: Feasibility and Impact of Morning Checkpoint Inhibitor Administration.
Pasquale F Innominato, Thierry Landré, Abdoulaye Karaboué, Boris Duchemann, Zachary S Buchwald

JCO Oncol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of adjuvant alectinib in the treatment of patients with resected stage IB-IIIA ALK-positive non-small lung cancer in France, based on the ALINA study.
Romain Supiot, Alexandre Gherardi, Léopoldine du Manoir de Juaye, Olfa Doghri, Marine Sivignon, Christos Chouaid

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review.
Hervé Bischoff, Sébastien Gendarme, Laura Somme, Christos Chouaid, Roland Schott

Curr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of advanced non-small cell lung cancer with ---skipping alterations: challenges remain after the Chrysalis study.
Christos Chouaïd, Jean-Baptiste Assié, Jean-Bernard Auliac

J Thorac Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the Letter of Mehmet Mutlu Çatlı, Arif Hakan Önder.
Antoine Bronstein, Olivier Bylicki, Christos Chouaid

Clin Lung Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis